Narrow search
Showing 1 - 10 of 331
Cover Image
On Size and Growth of Business Firms
De Fabritiis, Gianni; Riccaboni, Massimo; Pammolli, Fabio - Volkswirtschaftliche Fakultät, … - 2003
We study size and growth distributions of products and business firms in the context of a given industry. Firm size growth is analyzed in terms of two basic mechanisms, i.e. the increase of the number of new elementary business units and their size growth. We find a power-law relationship...
Persistent link: https://www.econbiz.de/10005020505
Cover Image
28th out of 30: Poor medicine and unhealthy Americans
Fullbrook, Edward - Volkswirtschaftliche Fakultät, … - 2009
In 1970 the USA spent 7% of its GNP on healthcare, in 200716%. Whereas the OECD average per capita expenditure on healthcare in 2007 was $2,964, the USA spent $7,290. Yet in that same period, the health of America’s citizens relative to those of other developed countries declined dramatically,...
Persistent link: https://www.econbiz.de/10008544705
Cover Image
FDI spillovers and local productivity growth: evidence from Indian pharmaceutical industry
Pradhan, Jaya Prakash - Volkswirtschaftliche Fakultät, … - 2004
The study tests the FDI spillover hypothesis in the Indian Pharmaceutical industry using an unbalanced panel data for a sample of firms over the period 1989-90 to 2000-01. The study estimates firm-specific productive efficiency growth for domestic firms from frontier production function and...
Persistent link: https://www.econbiz.de/10005059093
Cover Image
Market Structure and Drug Innovation
Pammolli, Fabio; Riccaboni, Massimo - Volkswirtschaftliche Fakultät, … - 2004
measures that are affecting demand for pharmaceuticals in all major markets. This Perspective considers the impact of the …
Persistent link: https://www.econbiz.de/10005109573
Cover Image
Preferential attachment and growth dynamics in complex systems
Yamasaki, Kazuko; Matia, Kaushik; Buldyrev, Sergey V.; … - Volkswirtschaftliche Fakultät, … - 2004
, which covers both elementary units (products) and classes (markets, firms) in a given industry (pharmaceuticals), covering …
Persistent link: https://www.econbiz.de/10005031401
Cover Image
Betweenness Centrality of Fractal and Non-Fractal Scale-Free Model Networks and Tests on Real Networks
Kitsak, Maksim; Havlin, Shlomo; Paul, Gerald; … - Volkswirtschaftliche Fakultät, … - 2007
We study the betweenness centrality of fractal and non-fractal scale-free network models as well as real networks. We show that the correlation between degree and betweenness centrality C of nodes is much weaker in fractal network models compared to non-fractal models. We also show that nodes of...
Persistent link: https://www.econbiz.de/10005031411
Cover Image
Global Competitiveness in Pharmaceuticals: A European Perspective
Gambardella, Alfonso; Orsenigo, Luigi; Pammolli, Fabio - Volkswirtschaftliche Fakultät, … - 2000
position of the US as a locus of innovation in pharmaceuticals has increased over the past decade compared to Europe. All in … in pharmaceuticals: 1) The size and the structure of the biomedical education and research systems; 2) Some basic …) Intellectual property rights and patent law; 4) The institutional settings in the regulation of health care systems and, moreover …
Persistent link: https://www.econbiz.de/10005034968
Cover Image
Mergers and Acquisitions in the Indian Pharmaceutical Industry: Nature, Structure and Performance
Beena, S - Volkswirtschaftliche Fakultät, … - 2006
This paper tries to address the extent, nature and impact of the recent surge in consolidation strategies especially in the form of mergers and acquisitions followed by the firms in the Indian pharmaceutical industry. The study found that many of the firms are implementing these strategies in...
Persistent link: https://www.econbiz.de/10005620025
Cover Image
Market Structure and Competition: Assessment of Malaysian Pharmaceutical Industry based on the Modified Structure-Conduct-Performance Paradigm
Chong, Hooi Ying; Chan, Tze-Haw - Volkswirtschaftliche Fakultät, … - 2014
This study assesses the market structure and competitiveness of Malaysian pharmaceutical industry. A panel analysis of 41 pharmaceutical manufacturing firms over 2004-2012 is conducted founded on the modified Structure-Conduct-Performance (SCP) framework. Our study reveals that the Malaysian...
Persistent link: https://www.econbiz.de/10011107532
Cover Image
Gifts and sponsored trips for doctors matter more for sales of MNCs?(an application of censored regression)
Hasan, Syed Akif; Subhani, Muhammad Imtiaz; Osman, Ms. Amber - Volkswirtschaftliche Fakultät, … - 2012
This study investigates and interrogates the impact of various marketing strategies on the sales of major multinational pharmaceutical companies in Pakistan; include Abbott, GSK and Aventis, while applying the censored regression. Besides interrogating the possible impacts of various marketing...
Persistent link: https://www.econbiz.de/10011108704